(Q64120995)
Statements
Sorafenib Alone or in Combination With Everolimus in Patients With Unresectable Hepatocellular Carcinoma. A Randomized Multicenter Phase II Trial. (English)
0 references
November 2009
0 references
June 2013
0 references
106
0 references
18 year
0 references